Sedana Medical AB (OSTO:SEDANA) COGS-to-Revenue : 0.29 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Sedana Medical AB COGS-to-Revenue?

Sedana Medical AB's Cost of Goods Sold for the three months ended in Mar. 2024 was kr14.1 Mil. Its Revenue for the three months ended in Mar. 2024 was kr48.8 Mil.

Sedana Medical AB's COGS to Revenue for the three months ended in Mar. 2024 was 0.29.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Sedana Medical AB's Gross Margin % for the three months ended in Mar. 2024 was 71.22%.

Sedana Medical AB COGS-to-Revenue Historical Data

The historical data trend for Sedana Medical AB's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sedana Medical AB COGS-to-Revenue Chart

Sedana Medical AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.35

0.37

0.33

0.30

0.29

Sedana Medical AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.27	0.29	0.30	0.30	0.29

Sedana Medical AB COGS-to-Revenue Calculation

Sedana Medical AB's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	44.886	/	153.867
	=	0.29

Sedana Medical AB's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	14.052	/	48.821
	=	0.29

Sedana Medical AB (OSTO:SEDANA) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Sedana Medical AB's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	14.052 / 48.821
	=	71.22 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Sedana Medical AB COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sedana Medical AB's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sedana Medical AB (OSTO:SEDANA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sedana Medical AB (OSTO:SEDANA) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

7D2A:Germany

Address

Vendevagen 89, Danderyd, SWE, SE-182 32

Website

https://www.sedanamedical.com

Sedana Medical AB is a Sweden-based medical technology company. It's Anaesthetic Conserving Device (AnaConDa) is an anaesthetic delivery system developed for the administration of volatile anaesthetics such as isoflurane or sevoflurane to invasively ventilated patients. AnaConDa is a small device that is inserted in the breathing circuit between the ET-Tube and the Y-piece. The product range of the group is AnaConDa, AnaConDa-S, AnaConDa syringe, FlurAbsorb-S, FlurAbsorb accessory kit, Nafion line, and others. The company operates in Sweden, Germany, Spain, Ireland, and France, out of which Germany accounts for the majority of the revenue.

Sedana Medical AB (OSTO:SEDANA) Headlines

No Headlines